Cargando…
Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong
BACKGROUND: Dabigatran, an oral direct thrombin inhibitor, possesses several advantages over warfarin that can in principle simplify the management of stroke prevention in atrial fibrillation (AF). Nonetheless it remains unclear whether these advantages can translate to clinical practice and encoura...
Autores principales: | Ho, Mei Han, Ho, Chi Wai, Cheung, Emmanuel, Chan, Pak Hei, Hai, Jo Jo, Chan, Koon Ho, Chan, Esther W., Leung, Gilberto Ka Kit, Tse, Hung Fat, Siu, Chung Wah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118845/ https://www.ncbi.nlm.nih.gov/pubmed/25084117 http://dx.doi.org/10.1371/journal.pone.0101245 |
Ejemplares similares
-
Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry
por: Hai, Jo-Jo, et al.
Publicado: (2016) -
Burden of upper gastrointestinal symptoms in patients prescribed dabigatran for stroke prevention
por: Chan, Pak-Hei, et al.
Publicado: (2016) -
Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology
por: Ma, Wai‐Kit, et al.
Publicado: (2019) -
Quinidine for Brugada syndrome: Panacea or poison?
por: Hai, Jo-Jo, et al.
Publicado: (2016) -
Modelling the impact of travel restrictions on COVID-19 cases in Hong Kong in early 2020
por: Kwok, Wang-Chun, et al.
Publicado: (2021)